WW

Wassihun Wedajo Aragaw

Center for Discovery and Innovation, Hackensack Meridian Health

Affiliated withHackensack Meridian Health Hackensack Meridian Health

Research Area

Biography

Wassihun Wedajo Aragaw has not added Biography.
If you are Wassihun Wedajo Aragaw and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2025

Other Publications

Article	Year
PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme Inhibitor. ACS chemical biology\| PubMed ID: 33984234	2021
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus. Antimicrobial agents and chemotherapy\| PubMed ID: 34001512	2021
Reinvestigation of the structure-activity relationships of isoniazid. Tuberculosis (Edinburgh, Scotland)\| PubMed ID: 34116482	2021
Potency boost of a dihydrofolate reductase inhibitor by multienzyme FH-dependent reduction. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 34161270	2021
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus. Antimicrobial agents and chemotherapy\| PubMed ID: 34606340	2021
Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice. Antimicrobial agents and chemotherapy\| PubMed ID: 34723632	2022
Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. Microbiology spectrum\| PubMed ID: 35019671	2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study. Antimicrobial agents and chemotherapy\| PubMed ID: 35099272	2022
Structural and Mechanistic Insights into Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor. ACS infectious diseases\| PubMed ID: 35731701	2022
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. Antimicrobial agents and chemotherapy\| PubMed ID: 36920191	2023
Synthesis and Characterization of Phenylalanine Amides Active against and Other Mycobacteria. Journal of medicinal chemistry\| PubMed ID: 37001025	2023
Characterization of Resistance to Linezolid in Mycobacterium abscessus. Microbiology spectrum\| PubMed ID: 37458588	2023
Pharmacological validation of dihydrofolate reductase as a drug target in . Antimicrobial agents and chemotherapy\| PubMed ID: 38018963	2024
A pairwise approach to revitalize β-lactams for the treatment of TB. Antimicrobial agents and chemotherapy\| PubMed ID: 38690896	2024
Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of . Antimicrobial agents and chemotherapy\| PubMed ID: 39470195	2024
Durlobactam to boost the clinical utility of standard of care β-lactams against lung disease. Antimicrobial agents and chemotherapy\| PubMed ID: 39565116	2025